COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,786 Articles (22,946 medRxiv, 8,840 bioRxiv)

Most recent first Previous |  Page 1167: Articles 11661-11670  | Next

Distinct SARS-CoV-2 sensing pathways in pDCs driving TLR7-antiviral vs. TLR2-immunopathological responses in COVID-19
van der Sluis, R. M., Cham, L. B., Oliver, A. G., Gammelgaard, K. R., Pedersen, J. G., Idorn, M., Ahmodov, U., Hernandez, S. S., Cemalovic, E., Godsk, S. H., Thyrsted, J., Gunst, J. D., Nielsen, S. D., Jorgensen, J. j., Bjerg, T. W., Laustsen, A., Reinert, L., Olagnier, D., Bak, R. O., Kjolby, M., Holm, C. K., Tolstrup, M., Paludan, S. R., Kristensen, l. S., Sogaard, O. S., Jakobsen, M. R.
10.1101/2021.11.23.469755 — Posted: 2021-11-24
A population framework for predicting the proportion of people infected by the far-field airborne transmission of SARS-CoV-2 indoors
Iddon, C., Jones, B., Sharpe, P., Cevik, M., Fitzgerald, S.
10.1101/2021.11.24.21266807 — Posted: 2021-11-24
Atazanavir is a competitive inhibitor of SARS-CoV-2 Mpro, impairing variants replication in vitro and in vivo
Chaves, O. A., Sacramento, C. Q., Ferreira, A. C., Mattos, M., Fintelman-Rodrigues, N., Temerozo, J. R., Pinto, D. P., da Silveira, G. P. E., da Fonseca, L. B., Pereira, H. M., Carlos, A. S., d'Avila, J. d. C. P., Viola, J. P. B., Monteiro, R. Q., Vazquez, L., Bozza, P. T., Castro-Faria-Neto, H. C., Souza, T. M. L.
10.1101/2021.11.24.469775 — Posted: 2021-11-24
Determining international spread of novel B.1.1.523 SARS-CoV-2 lineage
Zemaitis, L., Alzbutas, G., Gecys, D., Komissarov, A., Pautienius, A., Ugenskiene, R., Sukys, M., Lesauskaite, V.
10.1101/2021.11.21.21266655 — Posted: 2021-11-24
Establishing and characterising large COVID-19 cohorts after mapping the Information System for Research in Primary Care in Catalonia to the OMOP Common Data Model
Burn, E., Fernandez-Bertolin, S., Voss, E. A., Blacketer, C., Aragon, M., Recalde, M., Roel, E., Pistillo, A., Raventos, B., Reyes, C., van Sandijk, S., Halvorsen, L., Rijnbeek, P. R., Duarte-Salles, T.
10.1101/2021.11.23.21266734 — Posted: 2021-11-24
Impacts of vaccination and asymptomatic testing on SARS-CoV-2 transmission dynamics in a university setting
Nixon, E. J., Thomas, A. C., Stocks, D. A., Barreaux, A. M. G., Hemani, G., Trickey, A., Kwiatkowska, R., Walker, J. G., Ellis, D., Danon, L., Relton, C., Christensen, H., Brooks Pollock, E.
10.1101/2021.11.22.21266565 — Posted: 2021-11-24
Factors associated with COVID-19 vaccine acceptance and hesitancy among residents of Northern California jails
Liu, Y. E., Oto, J., Will, J., LeBoa, C., Doyle, A., Rens, N., Aggarwal, S., Kalish, I., Rodriguez, M., Sherif, B., Trinidad, C., del Rosario, M., Allen, S., Spencer, R., Morales, C., Chyorny, A., Andrews, J. R.
10.1101/2021.11.22.21266559 — Posted: 2021-11-24
Development and Performance verification of colloidal gold labeled SARS-CoV-2 antigen detection method for routine popular screening of COVID-19 with clinical samples in Poland and China
Guo, C., Yao, L., Chen, F., Zhang, C., Chen, W.
10.1101/2021.11.22.21266719 — Posted: 2021-11-24
The Failures of an Ideal COVID-19 Vaccine: A Simulation Study
Kosinski, R. J.
10.1101/2021.11.22.21266669 — Posted: 2021-11-24
Final sizes and durations of new COVID-19 pandemic waves in Ukraine and around the world predicted by generalized SIR model
Nesteruk, I.
10.1101/2021.11.22.21266683 — Posted: 2021-11-24

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).